EcoDrugPlus

Protein O-Fucosyltransferase 2

Ensembl ID : ENSORLG00000026033
Gene Symbol: POFUT2
3 Cross references
156 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSORLG00000012353
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSORLG00000013842
Gene Symbol: PRKCA
4 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSORLG00000020889
Gene Symbol: PRKCB
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSORLG00000008705
Gene Symbol: LOC101161464
4 Cross references
223 Possible Orthologues:

Protein Kinase C Delta Type

Ensembl ID : ENSORLG00000007871
Gene Symbol: LOC101162283
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSORLG00000003528
Gene Symbol: PRKCE
4 Cross references
246 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSORLG00000001443
Gene Symbol: PRKCDA
4 Cross references
204 Possible Orthologues:

Protein Kinase C, Epsilon A

Ensembl ID : ENSORLG00000010344
Gene Symbol: PRKCEA
3 Cross references
245 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSORLG00000015712
Gene Symbol: PRKCHA
4 Cross references
224 Possible Orthologues:

Protein Kinase C, Iota

Ensembl ID : ENSORLG00000017963
Gene Symbol: PRKCI
4 Cross references
87 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSORLG00000016894
Gene Symbol: PRKCQ
4 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).